MRD-Guided Therapy in CLL

Dr. Michael Bierer introduces the trial comparing ibrutinib–venetoclax, ibrutinib, and FCR, highlighting MRD and progression-free survival findings.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!